Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Starbucks
SBUX
|
+$618M |
| 2 |
Vale
VALE
|
+$332M |
| 3 |
CELG
Celgene Corp
CELG
|
+$309M |
| 4 |
CME Group
CME
|
+$306M |
| 5 |
Amazon
AMZN
|
+$290M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$435M |
| 2 |
Meta Platforms (Facebook)
META
|
+$342M |
| 3 |
Crown Castle
CCI
|
+$244M |
| 4 |
SLB Ltd
SLB
|
+$229M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$190M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.17% |
| 2 | Technology | 14.41% |
| 3 | Consumer Discretionary | 10.61% |
| 4 | Financials | 10.51% |
| 5 | Real Estate | 9.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3226
Soligenix
SNGX
$5.78M
| $178K | ﹤0.01% |
811
+55
| +7% | +$12.4K |
|
3227
Cemtrex
CETX
$5.2M
| – | – |
0
| – | – |
|
|
EMX
3228
DELISTED
EMX Royalty
EMX
| $175K | ﹤0.01% |
149,200
+45,458
| +44% | +$53.7K |
|
3229
United Natural Foods
UNFI
$2.9B
| $173K | ﹤0.01% |
13,100
-848,650
| -98% | -$11.5M |
|
|
MAMS
3230
DELISTED
MAM Software Group Inc. New
MAMS
| $172K | ﹤0.01% |
20,200
-3,505
| -15% | -$29.1K |
|
|
JMP
3231
DELISTED
JMP Group LLC
JMP
| $171K | ﹤0.01% |
45,633
+17,800
| +64% | +$75.9K |
|
|
AHPI
3232
DELISTED
Allied Healthcare Products
AHPI
| $168K | ﹤0.01% |
92,140
+2,000
| +2% | +$3.73K |
|
|
SDRL
3233
DELISTED
Seadrill Limited Common Stock
SDRL
| $168K | ﹤0.01% |
20,253
-156,019
| -89% | -$1.41M |
|
3234
Danaos Corp
DAC
$2.55B
| $167K | ﹤0.01% |
13,493
+154
| +1% | +$1.95K |
|
3235
Key Tronic
KTCC
$41.9M
| $167K | ﹤0.01% |
27,000
+8,500
| +46% | +$54.6K |
|
3236
Comstock Holding Companies
CHCI
$152M
| $165K | ﹤0.01% |
75,884
+5,200
| +7% | +$11.5K |
|
3237
Rockwell Medical
RMTI
$29.6M
| $165K | ﹤0.01% |
+264
| New | +$120K |
|
|
ARTX
3238
DELISTED
Arotech Corporation
ARTX
| $160K | ﹤0.01% |
54,700
+24,300
| +80% | +$77.6K |
|
3239
SITE Centers
SITC
$156M
| $159K | ﹤0.01% |
+14,996
| New | +$152K |
|
3240
SiNtx Technologies
SINT
$9.98M
| $158K | ﹤0.01% |
1
| – | – |
|
|
RRTS
3241
DELISTED
RoadRunner Transportation Systems, Inc.
RRTS
| $158K | ﹤0.01% |
+15,071
| New | +$184K |
|
3242
Fulgent Genetics
FLGT
$515M
| $155K | ﹤0.01% |
+26,100
| New | +$120K |
|
3243
Prothena Corp
PRTA
$475M
| $155K | ﹤0.01% |
+12,800
| New | +$160K |
|
3244
Traws Pharma
TRAW
$8.12M
| $154K | ﹤0.01% |
125
-1
| -0.8% | -$1.19K |
|
|
CCRN
3245
DELISTED
Cross Country Healthcare
CCRN
| $153K | ﹤0.01% |
21,800
+8,000
| +58% | +$68.6K |
|
|
LFT
3246
Lument Finance Trust
LFT
$36.5M
| $153K | ﹤0.01% |
+43,934
| New | +$149K |
|
3247
Fennec Pharmaceuticals
FENC
$414M
| $151K | ﹤0.01% |
+31,100
| New | +$204K |
|
|
BDRX
3248
Biodexa Pharmaceuticals
BDRX
$1.54M
| – | – |
0
| – | – |
|
3249
Denison Mines
DNN
$2.98B
| $150K | ﹤0.01% |
289,000
+37,100
| +15% | +$19.2K |
|
|
ROYT
3250
DELISTED
PACIFIC COAST OIL TRUST
ROYT
| $150K | ﹤0.01% |
70,200
+2,000
| +3% | +$3.83K |
|
Similar funds
Jim Simons's Q1 2019 Portfolio in Review
As of Q1 2019, Jim Simons held 3,883 positions worth $110B, up 20% from $91.3B the previous quarter. Its ten largest holdings account for 8.7% of the portfolio.
Jim Simons deployed $7.09B of net new capital in Q1 2019, opening 532 new positions and adding to 1,751 existing holdings. Its largest new stake was Amazon: 3,483,100 shares worth $310M.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 15% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $342M trimmed.
- Jim Simons's largest Q1 2019 buy was Amazon: 3,483,100 shares worth $310M.
- Jim Simons added most to Starbucks in Q1 2019, an estimated $618M increase.
- Jim Simons's biggest Q1 2019 reduction was Meta Platforms (Facebook), cutting an estimated $342M.
- Jim Simons fully exited Apple in Q1 2019, selling an estimated $435M.
- Jim Simons's ten largest holdings make up 8.7% of its $110B portfolio in Q1 2019.
- Jim Simons opened 532 new positions and closed 465 in Q1 2019.
- Jim Simons's portfolio value rose 20% quarter-over-quarter to $110B.
Based on Renaissance Technologies's 13F filing for Q1 2019, filed 14 May 2019.